Fiasp ultra-fast-acting, Injektionslösung

7680662020016 CH-66202 Injektionslösung
Fiasp ultra-fast-acting, Injektionslösung
Fiasp ultra-fast-acting, Injektionslösung
Fiasp ultra-fast-acting, Injektionslösung
1 / 3
google

Article details

Package size
1 x 10
Selling units
1
Measure
ml
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
05/01/2023
Patient information leaflet
Français
05/01/2023
Patient information leaflet
Italien
05/01/2023

Detailed composition

Substance Quantity Type Category
(N/A)
600.0 NMOL Substance Wirkstoff (Principe actif)
(N/A)
100.0 U Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.5 MG Substance Konservierungsstoff (Conservateur)
(N/A)
1.72 MG Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 39.20
Specialties list
Yes
Generic
No
SL addition date: 01/07/2017

Authorization holder

Novo Nordisk Pharma AG

8302 Kloten

Authorization information

Swissmedic authorization number
66202
Drug name
Fiasp ultra-fast-acting, Injektionslösung
Galenic form
LSPA
ATC Code
A10AB05
Authorization status
Z
Dispensing category
B
First authorization
07/06/2017
Authorization expiration date
31/12/9999
IT Number
07.06.1.
Domain
Human medicine
Field of application
Diabetes mellitus

Package details

Description (FR)
FIASP sol inj 100 U flac 10 ml
Description (DE)
FIASP Inj Lös 100 E Durchstf 10 ml
Market launch
07/06/2017
Narcotic (BTM)
No